Xenopus allantoicase: molecular cloning, enzymatic activity and developmental expression

Area of Science:

• Biochemistry
• Evolutionary Biology
• Molecular Biology

Background:

• Allantoicase is a purine degradation enzyme.
• This enzyme, along with uricase and allantoinase, is notably absent in mammalian evolution.
• While found in some fungi, fish, and amphibians, its presence and function in vertebrates are less understood.

Purpose of the Study:

• To clone and characterize the allantoicase enzyme from Xenopus.
• To investigate the expression patterns and enzymatic activity of allantoicase in Xenopus.
• To examine the developmental expression of allantoicase during Xenopus embryogenesis.

Main Methods:

• Screening of a Xenopus liver cDNA expression library.
• cDNA cloning and sequence analysis.
• Quantitative analysis of mRNA expression via Northern blotting (implied).
• Enzymatic activity assays and kinetic parameter determination (Km, Vmax).

Main Results:

• A 1491-bp cDNA encoding a 389 amino acid protein with high similarity to allantoicase was cloned from Xenopus liver.
• Allantoicase mRNA is highly expressed in kidney and liver, with lower levels in brain, testis, intestine, and lung.
• Enzymatic activity was detected in kidney, liver, and lung extracts, with specific kinetic parameters determined for the kidney enzyme.
• Allantoicase transcript was detected from day 1 and activity from day 5 of Xenopus embryonic development.

Conclusions:

• The study successfully cloned and characterized Xenopus allantoicase, providing insights into purine metabolism in amphibians.
• The findings highlight tissue-specific expression and developmental regulation of allantoicase.
• This research contributes to understanding the evolutionary loss of purine degradation enzymes in mammals.